Open AccessDOAJ SealDOAJCrossrefOpenAlex
hLife
Metadata for this journal is being automatically enriched from connected scholarly data sources.
Journal information
- Publisher
- Elsevier
- Subjects
- Antibiotic Resistance in Bacteria · COVID-19 Clinical Research Studies · drugs · Gut microbiota and health · immunology · Immunotherapy and Immune Responses · interferon and immune responses · Medicine · Mosquito-borne diseases and control · pathogen biology · R · SARS-CoV-2 and COVID-19 Research · structural biology · translational medicine · vaccines · vaccines and immunoinformatics approaches
- Country
- NL
- Languages
- EN
- ISSN
- 2949-9283
- E-ISSN
- 2949-9283
- ISSN-L
- 2949-9283
- Open access
- Yes
- OA since
- 2023
- Publication years
- 2023–2026
- APC (summary)
- —
- Website
- Visit journal ↗
Journal Classification
Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.
- Classification
- Field / Subfield
- Primary Field
- Medicine
- Primary Subfield
- Infectious Diseases
- Domain
- Health Sciences
- Confidence
- Low
- Publications classified
- 132
- Classification version
- OAJF Classification v1.1
APC records
- OPENALEX · 2026
- 2,150 EUR
- OPENALEX · 2026
- 1,840 GBP
- OPENALEX · 2026
- 285,270 JPY
- OPENALEX · 2026
- 2,300 USD
- DOAJ · 2026
- 2,300 USD
